Phase II Study of Cetuximab As First-Line Single-Drug Therapy in Patients With Unresectable Squamous Cell Carcinoma of the Skin
E. Maubec(Inserm), Marie‐Françoise Avril(Délégation Paris 7)
Cited by 463
Related Papers
Genome-wide association study identifies three new melanoma susceptibility loci
|Nature Genetics|2011|250
Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility
|Nature Genetics|2020|238
Fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic tumors: European study of 113 cases
|Modern Pathology|2010|140
NKG2D/NKG2-Ligand Pathway Offers New Opportunities in Cancer Treatment
|Frontiers in Immunology|2019|95